Replies to post #24822 on Marker Therapeutics Inc (MRKR)

[Phantom Lord]

I'm still using the same valuation I have always used for my price target. I'm looking to settle somewhere between $15 - $20 by the start of Q2 next year. That's when we should see an uptick in news. As of right now my eyes are on the lookout for the S3. I'm expecting a big surprise there.